| Literature DB >> 34943598 |
Sinziana Ionescu1,2, Alin Codrut Nicolescu3, Octavia Luciana Madge1, Marian Marincas1,2, Madalina Radu4, Laurentiu Simion1,2.
Abstract
Tuberculosis (TB) is a public health issue that affects mostly, but not exclusively, developing countries. Abdominal TB is difficult to detect at first, with the incidence ranging from 10% to 30% of individuals with lung TB. Symptoms are non-specific, examinations can be misleading, and biomarkers commonly linked with other diseases can also make appropriate diagnosis difficult. As a background for this literature review, the method used was to look into the main characteristics and features of abdominal tuberculosis that could help with differentiation on the PubMed, Science Direct, and Academic Oxford Journals databases. The results were grouped into three categories: A. general features (the five forms of abdominal tuberculosis: wet and dry peritonitis, lymphadenopathy, lesions at the level of the cavitary organs, lesions at the level of the solid organs), B. different intra-abdominal organs and patterns of involvement (oesophageal, gastro-duodenal, jejunal, ileal, colorectal, hepatosplenic, and pancreatic TB with calcified lymphadenopathy, also with description of extraperitoneal forms), and C. special challenges of the differential diagnosis in abdominal TB (such as diagnostic overlap, the disease in transplant candidates and transplant recipients, and zoonotic TB). The study concluded that, particularly in endemic countries, any disease manifesting with peritonitis, lymphadenopathy, or lesions at the level of the intestines or solid organs should have workups and protocols applied that can confirm/dismiss the suspicion of abdominal tuberculosis.Entities:
Keywords: cyst; diagnosis; differential; granuloma; laparoscopy; laparotomy; lymphadenopathy; nodules; peritonitis; tuberculosis
Year: 2021 PMID: 34943598 PMCID: PMC8700228 DOI: 10.3390/diagnostics11122362
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418
Figure 1Flowchart illustrating the selection criteria employed in the current review.
Figure 2Choropleth map with consulted articles and their country of provenience.
List of countries, depicting the number of articles found during the search and grouped according to the first author’s country of provenience.
| Country Name | Number of Articles | Country Name | Number of Articles |
|---|---|---|---|
| Belgium | 1 | United States of America | 36 |
| Cameroon | 1 | India | 32 |
| Colombia | 1 | China | 17 |
| Democratic Republic of Congo | 1 | United Kingdom | 14 |
| Ecuador | 1 | Spain | 11 |
| Indonesia | 1 | Netherlands | 9 |
| Ireland | 1 | D. P. R. of Korea | 8 |
| Kosovo | 1 | Japan | 7 |
| New Zealand | 1 | France | 6 |
| Nigeria | 1 | Germany | 6 |
| Peru | 1 | Pakistan | 5 |
| Portugal | 1 | Brazil | 4 |
| Qatar | 1 | Australia | 3 |
| R. B. de Venezuela | 1 | South Africa | 3 |
| Romania | 1 | Turkey | 3 |
| Rwanda | 1 | United Arab Emirates | 3 |
| Saudi Arabia | 1 | Canada | 2 |
| Sudan | 1 | Denmark | 2 |
| Tanzania | 1 | Israel | 2 |
| Thailand | 1 | Italy | 2 |
| Uganda | 1 | Mexico | 2 |
| Zambia | 1 | Singapore | 2 |
Figure 3Main clinical manifestations of abdominal tuberculosis, and the main differential for each of them.
Figure 4Common surgical setting characteristics in abdominal tuberculosis.
Oesophageal tuberculosis and a comparison between the findings from different studies.
| Name of the Study, Journal Where It Was Published, and Year | Investigations Used, Purpose of the Study | Findings | Number of Cases |
|---|---|---|---|
| Kocaman, | Endosonography and elastography in the diagnosis of esophageal tuberculosis | Esophageal tuberculosis | Case report |
| V. D. Plat, | Comparing endoscopic repair with surgical repair in brochoesophageal fistulas | Fistulas were caused by postoperative complications or pulmonary TB | 16 cases |
| S.K. Jain, | Upper endoscopy | Pts with esophageal TB constituted 0.5% of pts with dysphagia and 1.3% of all pts with abnormal esophagoscopic findings | 12 cases |
| M.C. Borges, | Evaluate the role of PCR in the etiology of ulcers in HIV-1 infected pts | 96 biopsies from HIV infected pts were processed by specific PCR | 79 cases |
| S.Jain, | To study the utility of endoscopic cytology in the diagnosis of esophageal TB in clinically unsuspected cases | 228 cases of esophageal lesions | 8 cases |
Gastroduodenal tuberculosis: examples of literature studies and their key features.
| Review | Key-Features |
|---|---|
| P. Chaudhary, | Gastric TB is rare |
| M. Barat, | Duodenal Tb is rare, the disease more commonly affects the ileocecum, colon, and jejunum, while more than 90% of duodenal TB was also found to have co-infections with other parts of the intestine |
| S. Srisajjakul, | Duodenitis |
Rectal tuberculosis: literature studies and their key features.
| Study | Key-Features |
|---|---|
| Poras Chaudhary, | Rare, commonly misdiagnosed, curable with chemotherapy, surgery for complications |
| Jan Rakinic, | Anorectal fistulas |
| Puri, A.S., | Rectal Tb can cause strictures |
| Chaudhary, A., | Two cases of rectal strictures |
| Patil, S., | Rectal prolapse |
Splenic tuberculosis: literature studies and their key features.
| Study | Form of TB Encountered in the Study |
|---|---|
| MDCT Findings of splenic pathology, | Microabscess, splenomegaly |
| A review of the cysts of the spleen, | Peliosis |
| Improving diagnosis of atraumatic splenic lesions, | Calcified granuloma and peliosis |
| Splenic tuberculosis: a comprehensive review of literature, | Small splenomegaly, abscess+/- ascitis |
| Hypersplenism secondary to splenic tuberculosis, | Hypersplenism |
Pancreatic TB.
| Main Author | Main features of the research | Main aspects followed |
| Ray et al., | Pancreatic and peripancreatic nodal tuberculosis in immunocompetent patients: report of 3 cases | Description of pancreatic TB with contrast-enhanced ultrasound |
| Irfan M. Monaldi | Tb pancreatitis complicating with a ruptured splenic artery pseudoaneurysm | Emergency laparotomy for haemorrhage |
| D. Cruz S. | Pancreatic TB | FNA biopsy |
Diagnostic methods in tuberculosis, as per WHO consolidated guidelines on tuberculosis, Module 3: Diagnosis [46].
| Method, Category | Main Features | |
|---|---|---|
|
Microscopy | First line is auramine phenol staining, relying on the autofluorescence of the bacterial wall, followed in some labs by Ziehl-Neelsen staining [ | |
|
Culture | Gold standard for diagnosis, a positive culture is achieved in 2/3 of cases of extrapulmonary TB (automated liquid culture or solid culture Lowenstein Jensen) [ | |
|
Immunological methods | Tuberculin skin testing or interferon gamma release assay [ | |
|
DNA-based methods | Nucleic acid amplification tests or whole genome sequencing tests, used for the detection of mycobacteria, identification of the most common mutations, strain typing | |
| D.1. Initial tests for diagnosis of TB with drug-resistance detection |
Xpert MTB/RIF assay | The Xpert MTB/RIF assay is a cartridge-based automated test that uses real-time polymerase chain reaction (PCR) on the GeneXpert platform to identify MTBC and mutations associated with RIF resistance directly from sputum specimens in less than 2 h. |
|
Xpert MTB/RIF Ultra assay | The Xpert MTB/RIF Ultra assay (hereafter called Xpert Ultra) uses the same GeneXpert platform as the Xpert MTB/RIF test and was developed to improve the sensitivity and reliability of detection of MTBC and RIF resistance | |
|
Truenat MTB, MTB Plus and MTB-RIF Dx assays | The Truenat MTB and MTB Plus assays use chip-based real-time micro PCR for the semiquantitative detection of MTBC directly from sputum specimens and can report results in under an hour. The assays use automated, battery- operated devices that extract, amplify, and detect specific genomic DNA loci. | |
|
Moderate complexity automated NAATs | The moderate complexity of the automated NAATs class of tests includes rapid and accurate tests for the detection of pulmonary TB from respiratory samples. | |
| D.2. Initial tests for diagnosis of TB without drug-resistance detection |
TB-LAMP assay | The TB-LAMP assay is designed to detect MTBC directly from sputum specimens. This is a manual assay that provides results in less than 1 hour, does not require sophisticated instrumentation, and can be used at the peripheral health centre level, given biosafety requirements similar to those for sputum-smear microscopy. TB-LAMP does not detect resistance to anti-TB drugs. |
|
Urine LF-LAM | The urine LF-LAM is an immunocapture assay based on the detection of the mycobacterial LAM antigen in urine; it is a potential point-of-care test for certain populations being evaluated for TB. Although the assay lacks sensitivity, it can be used as a fast, bedside, rule-in test for HIV-positive individuals, especially in urgent cases, where a rapid TB diagnosis is critical for the patient’s survival. | |
| D.3. Follow-on diagnostic tests for detection of additional drug resistance |
Low complexity automated NAATs for detection of resistance to INH and second-line anti-TB drugs | The “first in class” product for low complexity automated NAATs for detection of resistance to INH and second-line anti-TB drugs is the Xpert MTB/XDR Assay (Cepheid, Sunnyvale, USA). This test uses a cartridge designed for the GeneXpert instrument to detect resistance to INH, FQs, ETO, and second-line injectable drugs (AMK, kanamycin and capreomycin) |
|
LPA s | LPAs are a family of DNA strip-based tests that detect mutations associated with drug resistance. They do this either directly, through binding DNA amplification products (amplicons) to probes targeting the most commonly occurring mutations (MUT probes), or indirectly, inferred by the lack of binding of the amplicons to the corresponding wild-type probes. | |
|
High complexity reverse hybridization NAAT | The “first in class” product for this class is the GenoScholar PZA-TB (Nipro, Osaka, Japan) for the detection of resistance to PZA. The GenoScholar PZA-TB test is based on the same principle as the FL-LPA and SL-LPA but requires the use of a large number of hybridization probes to cover the full | |
|
New methods, such as biosensors | The greatest potential and widespread use of biosensors for diagnosing Mycobacterium tuberculosis and drug resistance belong to DNA electrochemical biosensors (isoniazid and rifampin strains).Biosensors are increasingly being used to detect resistant strains of anti-TB antibiotics with high sensitivity and accuracy, and the speed of these sensory methods is also critical [ | |